BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15212593)

  • 1. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
    Frueh FW; Gurwitz D
    Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: the promise of personalized medicine.
    Hood E
    Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 7. The disruptive nature of personalized medicine technologies: implications for the health care system.
    Carlson RJ
    Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Personalized Medicine Coalition: goals and strategies.
    Abrahams E; Ginsburg GS; Silver M
    Am J Pharmacogenomics; 2005; 5(6):345-55. PubMed ID: 16336000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educating for personalized medicine: a perspective from oncology.
    Parkinson DR; Ziegler J
    Clin Pharmacol Ther; 2009 Jul; 86(1):23-5. PubMed ID: 19536120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conundrum of personalized cancer management, drug development, and economics.
    DeNardo GL
    Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: where and how could biomarkers be used in 2016?
    Finley Austin MJ; Babiss L
    AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness survey of parties involved in pharmacogenomics in Japan.
    Tamaoki M; Gushima H; Tsutani K
    Pharmacogenomics; 2007 Mar; 8(3):275-86. PubMed ID: 17324116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
    Musgrave E
    Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.
    Roman YM; Dixon DL; Salgado TM; Price ET; Zimmerman KM; Sargent L; Slattum PW
    Pharmacogenomics; 2020 Jun; 21(9):627-635. PubMed ID: 32425117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.